A detailed history of Ifm Investors Pty LTD transactions in Pfizer Inc stock. As of the latest transaction made, Ifm Investors Pty LTD holds 1,178,399 shares of PFE stock, worth $29.4 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
1,178,399
Previous 1,179,272 0.07%
Holding current value
$29.4 Million
Previous $33 Million 3.35%
% of portfolio
0.33%
Previous 0.34%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$27.7 - $31.39 $24,182 - $27,403
-873 Reduced 0.07%
1,178,399 $34.1 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $466,375 - $546,504
18,463 Added 1.59%
1,179,272 $33 Million
Q1 2024

Apr 22, 2024

BUY
$25.89 - $29.73 $113,734 - $130,603
4,393 Added 0.38%
1,160,809 $32.2 Million
Q4 2023

Jan 12, 2024

SELL
$26.13 - $33.94 $45,622 - $59,259
-1,746 Reduced 0.15%
1,156,416 $33.3 Million
Q3 2023

Oct 26, 2023

BUY
$32.09 - $37.51 $1.14 Million - $1.33 Million
35,484 Added 3.16%
1,158,162 $38.4 Million
Q2 2023

Jul 27, 2023

BUY
$36.12 - $41.79 $2.56 Million - $2.97 Million
70,975 Added 6.75%
1,122,678 $41.2 Million
Q1 2023

May 11, 2023

BUY
$39.39 - $51.28 $1.09 Million - $1.41 Million
27,578 Added 2.69%
1,051,703 $42.9 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $2.45 Million - $3.19 Million
58,601 Added 6.07%
1,024,125 $52.5 Million
Q3 2022

Oct 12, 2022

BUY
$43.76 - $53.42 $995,364 - $1.22 Million
22,746 Added 2.41%
965,524 $42.3 Million
Q2 2022

Jul 15, 2022

BUY
$46.53 - $55.17 $3.01 Million - $3.57 Million
64,745 Added 7.37%
942,778 $49.4 Million
Q1 2022

Apr 13, 2022

BUY
$45.75 - $56.69 $7.03 Million - $8.71 Million
153,642 Added 21.21%
878,033 $45.5 Million
Q4 2021

Jan 18, 2022

BUY
$41.32 - $61.25 $29.9 Million - $44.4 Million
724,391 New
724,391 $42.8 Million
Q3 2021

Oct 13, 2021

SELL
$39.25 - $50.42 $28.7 Million - $36.9 Million
-732,247 Closed
0 $0
Q2 2021

Jul 16, 2021

BUY
$35.91 - $40.68 $4.82 Million - $5.46 Million
134,309 Added 22.46%
732,247 $28.7 Million
Q1 2021

May 05, 2021

BUY
$33.49 - $37.77 $2.03 Million - $2.29 Million
60,557 Added 11.27%
597,938 $21.7 Million
Q4 2020

Jan 13, 2021

BUY
$33.47 - $42.56 $2.52 Million - $3.2 Million
75,149 Added 16.26%
537,381 $19.8 Million
Q3 2020

Oct 16, 2020

BUY
$31.75 - $37.25 $1.74 Million - $2.04 Million
54,711 Added 13.43%
462,232 $17 Million
Q2 2020

Jul 13, 2020

SELL
$30.12 - $36.54 $4.42 Million - $5.36 Million
-146,589 Reduced 26.45%
407,521 $13.3 Million
Q1 2020

Apr 09, 2020

SELL
$27.03 - $38.62 $499,081 - $713,079
-18,464 Reduced 3.22%
554,110 $18.1 Million
Q4 2019

Jan 13, 2020

SELL
$32.92 - $37.36 $940,656 - $1.07 Million
-28,574 Reduced 4.75%
572,574 $22.4 Million
Q3 2019

Nov 01, 2019

BUY
$32.49 - $42.13 $6.72 Million - $8.71 Million
206,832 Added 52.45%
601,148 $21.6 Million
Q2 2019

Jul 16, 2019

BUY
$36.98 - $41.52 $668,672 - $750,764
18,082 Added 4.81%
394,316 $17.1 Million
Q1 2019

Apr 18, 2019

BUY
$37.5 - $41.2 $1.37 Million - $1.51 Million
36,580 Added 10.77%
376,234 $16 Million
Q4 2018

Jan 23, 2019

BUY
$38.47 - $43.86 $1.18 Million - $1.35 Million
30,765 Added 9.96%
339,654 $14.8 Million
Q3 2018

Oct 22, 2018

BUY
$34.47 - $41.81 $1.36 Million - $1.65 Million
39,396 Added 14.62%
308,889 $13.6 Million
Q2 2018

Jul 09, 2018

BUY
$32.98 - $35.16 $2.77 Million - $2.95 Million
83,972 Added 45.26%
269,493 $9.78 Million
Q1 2018

May 11, 2018

BUY
$31.91 - $37.02 $596,557 - $692,088
18,695 Added 11.21%
185,521 $6.58 Million
Q4 2017

Jan 29, 2018

SELL
$33.26 - $35.29 $21,086 - $22,373
-634 Reduced 0.38%
166,826 $6.04 Million
Q3 2017

Nov 16, 2017

BUY
$31.0 - $34.15 $94,922 - $104,567
3,062 Added 1.86%
167,460 $5.98 Million
Q2 2017

Aug 10, 2017

BUY
N/A
41,097 Added 33.33%
164,398 $5.52 Million
Q1 2017

Aug 17, 2017

BUY
N/A
123,301
123,301 $4.22 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ifm Investors Pty LTD Portfolio

Follow Ifm Investors Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.